Sector: Pharmaceuticals & Biotechnology

Mid Cap

Cohance Lifesciences Share Price

COHANCE

₹451.25

-11.75(-2.54%)

24th Aug 2026 | 12:55 PM

NSE : COHANCE

Open Free Demat Account

Cohance Lifesciences Performance

Price Movement

₹451.25

₹450.00

₹460.25

↘ Today's Low↗ Today's High

1 Year Performance

₹451.25

₹266.70

₹1038.90

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹460.25

Low₹450.00

Open at₹458.45

Prev Close₹463.00

Volumes5.52 L

Avg Price₹452.98

Lower Circuit₹370.40

Upper Circuit₹555.60

Historical Performance

3M High₹486.30

3M Low₹403.40

1 Yr High₹1,038.90

1 Yr Low₹266.70

3 Yr High₹1,360.00

3 Yr Low₹266.70

5 Yr High₹1,360.00

5 Yr Low₹266.70

Summary

As of 24-08-2026 13:26, Cohance Lifesciences Ltd. share price today is ₹0, with a change of ₹-463.00 (-100.00%) from the previous close of ₹463. The stock opened at ₹458.45 and traded between ₹450 and ₹460.25, with a total traded volume of 552420 shares. The company has a market capitalization of ₹17096.4 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹1038.9 and ₹266.7, respectively.

Cohance Lifesciences Ltd. valuation metrics include a P/E ratio of 160.9, EPS of ₹4.69, and book value of ₹4.40. Profitability indicators show ROE of 4.58%. Cohance Lifesciences Ltd. has reported revenue of ₹2141.5 Cr and net profit of ₹106.23 Cr.

Cohance Lifesciences Ltd. technical indicators include Day RSI at 53.57, Day MFI at 87.61, Day ADX at 34.02. Additional indicators include Commodity Channel Index (CCI) at 73 and Williams %R at -48.18. Momentum indicators show Day MACD at 3.49, Day MACD Signal Line at 1.99, DayATR at 17.57. Rate of Change indicators for Cohance Lifesciences Ltd. include ROC125 at 41.59 and ROC21 at 0.27.

Exponential moving averages include EMA5 at ₹447.6, EMA10 at ₹445, EMA12 at ₹444.1, EMA20 at ₹441.7, EMA26 at ₹440.6, EMA50 at ₹436, EMA100 at ₹437.2, EMA200 at ₹503.4. Simple moving averages include SMA5 at ₹446.3, SMA10 at ₹447.2, SMA20 at ₹436.3, SMA30 at ₹438.6, SMA50 at ₹438.4, SMA100 at ₹420.2, SMA150 at ₹394.7, SMA200 at ₹442.1.

Support levels for Cohance Lifesciences are placed at First Support ₹441.20, Second Support ₹435.55, Third Support ₹427.05. Resistance levels are seen at First Resistance ₹455.35, Second Resistance ₹463.85, Third Resistance ₹469.50. Cohance Lifesciences Ltd. shareholding pattern shows promoter holding at 57.49%, FII holding at 6.5%, DII holding at 0%, public holding at 15.92%.

Cohance Lifesciences Fundamentals

Market Cap

High in industry

17,096.40 Cr.

PE Ratio (TTM)

High in industry

160.90

Dividend Yield

Net Profit TTM

58% decr over last year

106.23

Net Profit Growth

58% decr over last year

106.23

PEG Ratio

Negative PEG TTM

-2.80

ROE

71% decr over last year

4.58

Operating Revenue TTM

2,141.50

Operating Revenue Growth

41.2% incr over last year

Book Value

Above industry Median

4.40

MFI

MFI strongly Overbought

87.61

RSI

RSI is mid-range

53.57

EPS (TTM)

4.69

Debt to Equity

0.04

Face Value

Operating Profit Margin Qtr.

18.54

Operating Profit Qtr.

1.16

Net Profit Qtr.

-24.12

Operating Revenue Qtr.

422.26

PB Ratio

4.40

Cohance Lifesciences Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Total Revenue	359.89	567.55	481.58	497.79	483.58
Operating Expense	333.40	450.98	378.80	366.93	379.38
Operating Profit	26.49	116.57	102.78	130.86	104.20
Depreciation	34.32	37.66	33.36	31.20	31.36
Interest	2.12	5.17	5.25	5.24	6.80
Tax	0.80	21.88	18.14	26.43	18.47
Net Profit	1.41	34.56	47.29	94.29	52.57

Cohance Lifesciences Technicals

Cohance Lifesciences Ltd. EMA & SMA

₹451.25

-3.95 (-0.87%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹447.6

Day EMA10 ₹445

Day EMA12 ₹444.1

Day EMA20 ₹441.7

Day EMA26 ₹440.6

Day EMA50 ₹436

Day EMA100 ₹437.2

Day EMA200 ₹503.4

Cohance Lifesciences Support and Resistance

Resistance

First Resistance₹455.35

Second Resistance₹463.85

Third Resistance₹469.50

Support

First Support₹441.20

Second Support₹435.55

Third Support₹427.05

Technical Indicators

Day RSI53.57

Day MFI87.61

Day ADX34.02

Day Commodity Channel Index73.00

William-48.18

Day MACD3.49

Day MACD Signal Line1.99

Day ATR17.57

Day ROC12541.59

Day ROC210.27

Cohance Lifesciences Shareholding Pattern

Held By	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoter	50.1	66.4	57.5	57.5	57.5	57.5
FII	11	7.2	6.5	6	5.6	6.5
DII	16.7	11.4	20.8	21.6	21.8	20.1
Public	22.2	15	15.2	14.9	15.1	15.9

Cohance Lifesciences Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	1.41 L	3.18 L	44.32%
Week	3.76 L	10.01 L	37.55%
1 Month	5.52 L	11.53 L	47.86%
6 Month	7.25 L	29.23 L	24.82%

Cohance Lifesciences SWOT Analysis

Strengths7

Weakness21

Opportunity2

Threats3

Benjamin Graham Value Screen

Strong Momentum: Price above short, medium and long term moving averages

Expensive Performers (DVM)

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Overbought by Money Flow Index (MFI)

Companies with Low Debt

Cohance Lifesciences Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
09 Sep, 2022	1	INTERIM	12 Sep, 2022	Equity Share
09 Sep, 2022	5	SPECIAL	12 Sep, 2022	Equity Share
13 May, 2022	1	INTERIM	17 May, 2022	Equity Share
13 May, 2022	1	SPECIAL	17 May, 2022	Equity Share
15 Feb, 2022	1	INTERIM	16 Feb, 2022	Equity Share
15 Feb, 2022	2	SPECIAL	16 Feb, 2022	Equity Share
13 Aug, 2021	1	FINAL	17 Aug, 2021	Equity Share
17 Feb, 2021	1	INTERIM	18 Feb, 2021	Equity Share

Cohance Lifesciences Stock Comparison

Financials	Corona Remedies Ltd.	Sudeep Pharma Ltd.	Senores Pharmaceuticals Ltd.	OneSource Specialty Pharma Ltd.	Sanofi Consumer Healthcare India Ltd.	Akums Drugs & Pharmaceuticals Ltd.
Price (₹)	₹2,142.40	₹1,112	₹1,567.40	₹1,521.20	₹4,224.10	₹769.50
% Change	-0.01%	0.02%	3.57%	-0.90%	0.05%	2.60%
Revenue TTM (₹ Cr)	₹1,479.07	₹675.61	₹691.72	₹1,543.34	₹949.80	₹4,501.61
Net Profit TTM (₹ Cr)	₹199.03	₹182.64	₹126.37	₹-48.62	₹266	₹291.72
PE TTM	65.20	71.50	56.50	-358.60	36.60	40.60
1 Year Return	99.76	95.01	121.72	-17.12	-19	57.13
ROCE	31.54	24.22	15.60	0.59	-	11.40

Similar Stocks

INNOVACAP

Innova Captab Ltd.

₹ 1064.90

-2.17%

BLUEJET

Blue Jet Healthcare Ltd

₹ 592.40

-0.63%

CONCORDBIO

Concord Biotech Ltd.

₹ 1542.00

-1.86%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 834.50

+2.17%

SUPRIYA

Supriya Lifescience Ltd.

₹ 802.75

-0.34%

ALIVUS

Alivus Life Sciences Ltd.

₹ 1357.00

+0.45%

ERIS

Eris Lifesciences Ltd.

₹ 1325.00

-0.24%

SYNGENE

Syngene International Ltd.

₹ 401.15

-1.50%

APLLTD

Alembic Pharmaceuticals Ltd.

₹ 817.10

-0.57%

SPARC

Sun Pharma Advanced Research Company Ltd.

₹ 195.80

-0.46%

STAR

Strides Pharma Science Ltd.

₹ 982.20

-0.41%

FDC

FDC Ltd.

₹ 346.40

-0.63%

SHILPAMED

Shilpa Medicare Ltd.

₹ 851.60

+4.50%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 894.00

+1.55%

NATCOPHARM

Natco Pharma Ltd.

₹ 885.00

+0.29%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 2502.10

-2.29%

MARKSANS

Marksans Pharma Ltd.

₹ 319.30

-0.62%

ORCHPHARMA

Orchid Pharma Ltd.

₹ 1031.65

+2.95%

VIYASH

Viyash Scientific Ltd.

₹ 268.45

-2.72%

ASTRAZEN

AstraZeneca Pharma India Ltd.

₹ 7219.00

-2.65%

BLISSGVS

Bliss GVS Pharma Ltd.

₹ 571.40

-1.33%

SANOFI

Sanofi India Ltd.

₹ 3288.00

-1.93%

MOREPENLAB

Morepen Laboratories Ltd.

₹ 96.51

+0.52%

PGHL

Procter & Gamble Health Ltd.

₹ 5858.50

+0.51%

FAQ's on COHANCE

What is the current share price of Cohance Lifesciences Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Cohance Lifesciences Ltd. is ₹ 451.25 on the NSE and ₹ 451.6 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Cohance Lifesciences Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Cohance Lifesciences Ltd. is approximately ₹ 17096.4 Cr.

What are the PE and PB ratios for Cohance Lifesciences Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Cohance Lifesciences Ltd. is 160.9, and the Price-to-Book (PB) ratio is 4.4.

What is the 52-Week High and Low for Cohance Lifesciences Ltd.?

Over the past 52 weeks, the highest price reached by Cohance Lifesciences Ltd. shares was ₹ 1038.9, and the lowest price was ₹ 266.7.

Who are the major shareholders of Cohance Lifesciences Ltd.?

Significant shareholdings in Cohance Lifesciences Ltd. typically include entities such as:

Promoter
Mutual Funds
Public
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Cohance Lifesciences Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Cohance Lifesciences Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Cohance Lifesciences Ltd.?

Cohance Lifesciences Ltd. last declared a INTERIM dividend of ₹ 1 per share for the financial period ending 2022. The record date was set as 2022-09-09, and the payment was/is scheduled around 2022-09-09. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy